CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension

Jae Hyun Kim, Jung Min Kim, Youn Zoo Cho, Ji Hoon Na, Hyun Sik Kim, Hyoun A Kim, Hye Won Kang, Soon Koo Baik, Sang Ok Kwon, Seung Hwan Cha, Young Ju Kim, Moon Young Kim

Clin Mol Hepatol. 2014;20(4):376-383. Published online 2014 December 24 DOI: https://doi.org/10.3350/cmh.2014.20.4.376

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension

Jae Hyun Kim, Jung Min Kim, Youn Zoo Cho, Ji Hoon Na, Hyun Sik Kim, Hyoun A Kim, Hye Won Kang, Soon Koo Baik, Sang Ok Kwon, Seung Hwan Cha, Young Ju Kim, Moon Young Kim

Clinical and Molecular Hepatology. 2014;20(4):376

Link1 Link2

847 THE EFFECT OF ANGIOTENSIN RECEPTOR BLOCKER, CANDESARTAN AND NONSELECTIVE BETA BLOCKER, PROPRANOLOL COMBINATION THERAPY IN REDUCTION OF PORTAL HYPERTENSION COMPARED TO PROPRANOLOL MONTHERAPY

M.Y. Kim, S.K. Baik, C.S. Won, J.W. Byun, H.J. Park, H.J. Choi, S.Y. Park, Y.H. Kwon, G.J. Cheon, Y.D. Kim

Journal of Hepatology. 2010;52:S330

Link1 Link2

PROPRANOLOL IN PORTAL HYPERTENSION

The Lancet. 1984;323(8375):520

Link1 Link2

G03 : Rifaximin and propranolol combination therapy is more effective than propranolol monotherapy in the hepatic venous pressure gradient response and propranolol dose reduction – A pilot study

S.K. Baik, Y.L. Lim, Y.Z. Cho, M.Y. Kim, Y.O. Jang, K.T. Suk, G.J. Cheon, Y.D. Kim, D.H. Choi

Journal of Hepatology. 2015;62:S188

Link1 Link2

PROPRANOLOL FOR PORTAL HYPERTENSION

P. Dominguez

The Lancet. 1981;317(8233):1322-1323

Link1 Link2

PROPRANOLOL AND PORTAL HYPERTENSION IN CIRRHOSIS

S.P. Wilkinson

The Lancet. 1980;316(8191):429

Link1 Link2

Comparison of combination nifedipine-propranolol and diltiazem-propranolol with high dose diltiazem monotherapy for stable angina pectoris

John R. Morse

The American Journal of Cardiology. 1988;62(16):1028-1032

Link1 Link2

Use of Clonidine and Propranolol As Monotherapy in Borderline Hypertension

Christopher Cottier, Stevo Julius

Chest. 1983;83(2):422-425

Link1 Link2

Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study

Yoo Li Lim, Moon Young Kim, Yoon Ok Jang, Soon Koo Baik, Sang Ok Kwon

Gut and Liver. 2017;11(5):702-710

Link1

Link2

Propranolol (PR) alone versus the combination of endoscopic sclerotherapy (ES) and propranolol in the primary prevention of variceal haemorrhage in cirrhotics with varices. A multicenter, randomized trial

Gastroenterology. 1995;108(4):A1027

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.